Worldwide Sales of Sepsis Diagnostics are predicted to increase at a CAGR of 8.9% during the forecast period 2021-2031 | Roche Diagnostics, Thermo Fisher Scientific, Bruker Corporation, Abbott Laboratories

The global sepsis diagnostics market was valued at USD 503.4 million in 2021 and it is anticipated to grow up to USD 1181.5 million by 2031, at a CAGR of 8.9% during the forecast period.

To Remain 'Ahead' Of Your Competitors, Request for A Sample - https://www.globalinsightservices.com/request-sample/GIS10358

Sepsis is a potentially fatal illness that arises when the body's immune system attacks its own tissues in reaction to an infection. When the infection-fighting processes turn on the body, they cause organs to function poorly and abnormally.

Septic shock can develop from sepsis. This is a sudden reduction in blood pressure that can cause serious organ damage and even death. Treatment with antibiotics and intravenous fluids as soon as possible enhances the chances of survival.

Read More Report of Sepsis Diagnostics Market: https://www.globalinsightservices.com/reports/sepsis-diagnostics-market/

Market Trends and Drivers

Rising incidence of hospital-acquired infections will augment the market growth during the forecast period. Hospital-acquired infections (HAIs), also known as nosocomial infections, are a major cause of morbidity and mortality worldwide. The most common hospital-acquired infections (HAIs) are urinary tract infections, pneumonia, and sepsis. HAIs can lead to sepsis in immunocompromised patients, geriatric patients, and patients suffering from chronic illnesses.

Get a customized scope to match your, need ask an expert - https://www.globalinsightservices.com/request-customization/GIS10358

In the U.S., the incidence of sepsis among hospitalized patients is rising by 8.7% per year. It is estimated that there are more than 1,000,000 incidences of sepsis among hospitalized patients annually in the nation {Source: CDC, 2018). With the rapid increase in HAIs worldwide, the demand for sepsis diagnostic products is also expected to rise in the coming years.

Global Sepsis Diagnostics Market Segmentation

Product

Instruments
Blood Culture Media
Assay Kits and Reagents

Technology

Microbiology
Molecular Diagnostics
Immunoassays
Flow Cytometry

Pathogen

Bacterial Sepsis
Fungal Sepsis
Others

Testing Type

Laboratory Testing
PoC Testing
End-use

Hospitals and specialty clinics
Pathology & Reference Laboratories
Research Laboratories & Academic Institutes

For In-Depth Competitive Analysis, Purchase this Report - https://www.globalinsightservices.com/checkout/single_user/GIS10358

Major Players in the Global Sepsis Diagnostics Market

The key players in the market are bioMérieux (France), Becton, Dickinson and Company (US), Danaher Corporation (US), T2 Biosystems (US), Luminex (US), Roche Diagnostics (Switzerland), Thermo Fisher Scientific (US), Bruker Corporation (US) and Abbott Laboratories (US), among others.

New Report Published by Global Insight Services: https://www.globalinsightservices.com/reports/hydrogen-projects-database/

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.